RSS

CYDY CytoDyn Inc

Mod: mightycydy Asst: HHIGambler,CaptnAmerca
Last Post: 10:58 AM
Followers: 439
Posts Today: 4
Views Today: 77854

CYDY Stock Quote & Tools

$0.2150 ▲ +0.0096 (+4.69%) As of Oct 16, 12:34 PM EDT
Last0.2150
$ Chg0.0096
Open0.2050
High0.2190
Beta1.4964
Year High0.397
Market Cap315.95M
P/B Ratio-2.68
EPS-0.04
Avg Vol (30d)1.57M
Volume2.36M
% Chg+4.69%
Prev Close0.2054
Low0.2050
VWAP0.21094
Year Low0.183
Total Shares1.47B
Shares Out1.47B
Float1.36B
ExchangeOTCQB
Healthcare Biotechnology & Life Sciences
Company Profile Buy Rating Time & Sales News Filings Financials

CYDY Stock Message Board Discussion

3 Pinned Posts
Leronlimab (Pro 140) Cliff Notes What is it? Leronlimab is a humanized monoclo (43) by trding
Leronlimab Regulator List (a work in progress) = upregulation = downregulation a-SMA (21) by ohm20
EIND: Information to Submit to Doctors Leronlimab a humanized monoclonal antibody binds CCR5, (38) by ohm20
  1. kabonk

    https://www.medcalc.org/calc/relative_risk.php They get slightly different p-values for relative

    (2)
  2. viridi

    There is a very good analysis of severe/critical mortality rates across 10 covid clinical trials

    (5)
  3. nicehedges

    "post-leronlimab launch" I was thinking the same thing... he sounds pretty confident.

    (1)
  4. LaundryMoney

    Well Dr BP seems to think leronlimab will be out at some point.

    (9)
  5. CDiddy

    I would temper expectations. We wont hear anything today, or even this week IMO. Even if what

    (5)
  6. onestepahead

    https://www.cnn.com/2021/01/13/health/us-coronavirus-wednesday/index.html Unblinding data today

    (4)
  7. onestepahead

    They keep trying but the shorts are mainly just jumping each other back and fourth hoping for

    (4)
  8. Evil Rabbit

    Right out of the gate, the ask keeps dropping lower than the bid. Another day of manipulation

    (1)
  9. Giacomo27

    That chart looks like it should be an up day. Well see how we open here to see if we get a bar

  10. CTMedic

    Dfl, CCR5 is viral entry point for HIV. COVID uses ACE2. CCR5 d32 prevents hiv infection.

    (3)
  11. biloxiblues

    3.92 Euro equals 4.77 United States Dollar

    (1)
  12. dfwl28

    By definition doesn't having the delta mean that they are immune to covid and consequently there

    (3)
  13. Beasley

    My husband had the second Pfizer dose a week ago ( he works at the VA). He didn't have any side

  14. nmbr1stckpckr

    Its just too logical.

  15. sunclouds

    Ohm20 I am simply tying to explain that the data is being sent in by the trial sites throughout

    (10)
  16. onestepahead

    I believe the week before we were at roughly 370 so the most we could Have hit in the last week

  17. CTMedic

    Smurph, I got the vaccine that was available to me. The data indicates equal efficacy in

    (1)
  18. CTMedic

    Havasu, It may be splitting of hairs, but CCR5 delta 32, is a deletion of 32 base pairs in the

    (2)
  19. CTMedic

    Sean, Im getting the Pfizer vaccine. Im not certain if that is what you am were

  20. sean007

    havasu.....you have said it three times already.....gentic therapy.....I am sure you meant genetic

  21. lorbas

    Lol... true unfortunately.

  22. morokoy

    https://otce.finra.org/otce/equityShortInterest 28,551,479 at 12/31/20 An increase of 1,507,973

  23. havasu78

    CCR5delta32 status should also be collected on HIV patients. Heterozygous mutants should respond

    (1)
  24. morokoy

    Found this under Pipeline, HIV on the website. CytoDyn has submitted the first section

    (1)
  25. havasu78

    I agree, 8% heterozyzous patients in the LL arm, 20 patients, is not enough to draw any

    (1)
  26. havasu78

    No not a waste of time. If you test 1000 patients and you get zero CCR5delta32 homozygous

    (4)
  27. mtruong34

    Leronlimab mentioned for HIV.

  28. ohm20

    That means that 10% of all patients have significantly less CCR5 molecules. So if CCR5

    (1)
  29. mtruong34

    Regarding biology or chemistry, molecule can have different meanings. You're good havasu.

  30. DaveEL

    Not a scientific site... Wikipedia Protei

  31. JLang

    If their findings are correct, that would have been a waste of time & resources as one wouldn't

    (3)
  32. havasu78

    Oh sorry i get it now. LOL. proteins may not be molecules. my bad! Defiinition: Molecule, a

  33. ohm20

    Ohm, do you think LL can help on AU. I'm guessing AU is some form of dyslexia. I

  34. CDiddy

    Admittedly I am not a scientist. I know its a receptor, I have just never heard it referred to as

  35. havasu78

    CCR5 is a g-coupled protein receptor. Its a protein. Just one contiguous protein. Its "G" cuz

    (2)
  36. havasu78

    Totally agree. all that matters now is CD12. And we have a good shot. Totally agree that

  37. ohm20

    Phase 4 is not blinded. We recommend that any part of the interim report to the DMC that

    (1)
  38. SeeWhyDY

    I agree CD, I also think it would require a seperate trial and since only 10-15% of European

  39. havasu78

    "...immune to HIV infection. These lucky people are homozygous carriers of the mutated gene -

  40. CDiddy

    The only thing that matters right now is CD 12. I believe we have a good shot at this. If by

    (2)
  41. smurph

    CTMedic, are you going with Pfizer or Moderna, and why?

  42. SeeWhyDY

    Incorrect.... A genetic mutation known as CCR5-delta 32 is responsible for the two types of

  43. CDiddy

    Umm. I dont believe CCR5 is a molecule.

    (1)
  44. havasu78

    Sure phase 4 would be great for more specialized testing. And if CD12 gets a quick EUA, CYDY

    (1)
  45. havasu78

    CCR5delta32 homozygous mutants do not have any CCR5 molecules in their bodies. The CCR5 DNA is

  46. CDiddy

    Perhaps they will add these in a phase 4.

  47. SeeWhyDY

    CCR5delta32 T-Cells still have CCR5 receptors but they are shorter than general CCR5 receptors.

  48. havasu78

    Suggestion to CYDY: Recast LL as a gentic therapy. Of course its irrelevant if CD12 is already

    (2)
  49. havasu78

    for all the complaining i have done lately about CYDY, CYDY is not as bad as these guys.

    (2)
  50. havasu78

    Its not 44%, it could be 100%. Maybe these guys will save Pourhassan's bacon in the event of CD12

    (5)

Top 10 Most Recent News Articles

More News Articles

Top 5 Most Recently Viewed Articles

Breakthrough Phase 3 Results for Ziihera® in Cancer Treatment

Updated Category News Views 130

Significant Advances in Cancer Treatment with Ziihera® Zymeworks Inc., a pioneering biotechnology company, has recently shared groundbreaking results from the Phase 3 HERIZON-GEA-01 trial. This trial assessed the efficacy of Ziihera® (zanidatamab-hrii) when paired with chemotherapy, aiming to provide a new standard of care for patients with HER2-positive locally...

Continue Reading
Discover the Future of Green Hydrogen with NewHydrogen's Innovations

Updated Category News Views 209

NewHydrogen's Commitment to Green Hydrogen Development The Company's ThermoLoop technology aligns with Texas’ growing hydrogen economy. NewHydrogen, Inc. (OTCMKTS:NEWH) is propelling the green hydrogen landscape forward by joining the Texas Hydrogen Alliance. This collaboration aims to promote the accessibility and usage of green hydrogen, a substantial effort in one of...

Continue Reading
Karma Water Revives Beloved Pineapple Coconut Flavor for 2026

Updated Category News Views 114

Karma Water Revives Beloved Pineapple Coconut Flavor Karma Water, a brand celebrated for its innovative beverages, is excited to reintroduce the popular Pineapple Coconut Probiotic Water. This classic flavor returns to the lineup, enriched with upgraded health benefits tailored for today's consumers. A Refreshing Return The Pineapple Coconut flavor, originally debuting in...

Continue Reading
UPM Performance Highlights: Strategic Moves and Strong Cash Flow

Updated Category News Views 168

Strategic Update from UPM UPM-Kymmene Corporation has announced its financial performance for 2025, highlighting a robust finish to the year characterized by strong cash flow and decisive strategic actions aimed at reshaping its business landscape. Key Highlights from Q4 2025 Sales reached €2,312 million, showing a decrease from Q4 2024 when sales were €2,632 million....

Continue Reading
Radcred's Instant Loan Platform Transforms Payday Lending

Updated Category News Views 249

Understanding the Revolution in Payday Lending Radcred, a prominent player in the fintech arena, has recently unveiled an innovative loan platform tailored for borrowers in the U.S. This new service specializes in online payday loans that promise rapid approval times without the burden of a credit check. It stands as an ideal solution for individuals facing urgent...

Continue Reading